Amgen to Receive $200 Million Upfront Payment, $702 Million in Multi-year Global R&D Expense Sharing and Success-based Milestones, and Double Digit Royalties on Japan Sales; Takeda Will Receive Exclusive Rights to Develop and Commercialize Select Molecules in Japan
Following a joint meeting today of the U.S. Food and Drug Administration FDA Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development TGRD underscores its position that ACTOS® pioglitazone HCl offers a proven safety profile regarding the risk of...
Tokyo, July 29, 2005 - JCN - Takeda Pharmaceutical announced on July 27 that one of its US affiliates, Takeda Global Research & Development Center of Illinois, has received fast track designation by the US Food and Drug Administration FDA for TAK-242, its investigational compound designed for the treatment of...
Tokyo, Feb 20, 2006 - JCN - Takeda Pharmaceutical and Hitachi jointly announced February 20 the establishment of Hitachi Inspharma, Ltd., a joint venture to support and develop information systems for the medical and pharmaceutical industries.
Takeda Pharmaceutical (TSE: 4502) and Wyeth jointly announced on March 29 that they will begin distributing ENBREL, an injection solution for the treatment of rheumatoid arthritis RA, on March 30.
ST. PAUL, Minn. & OSAKA, Japan -- 3M and Takeda Pharmaceutical Company Limited Takeda announced today that the two companies entered into an exclusive co-development and joint marketing agreement to collaborate on a potential topical treatment for cervical high-risk human papillomavirus HPV infection and cervical dysplasia.
Tokyo, Oct 7, 2005 - JCN - Hitachi and Takeda Pharmaceutical jointly announced on October 3 that the two companies have basically agreed to establish a joint venture company for information system service as of September 29.
BASF Akt, Ludwigshafen, tel:+49 621 60-9 9938, and Takeda Chemical Industries Ltd, Osaka, Japan, have agreed to combine their bulk vitamins businesses, which includes transferring part of Takeda's assets. The agreement has been approved by the respec BASF Akt, Ludwigshafen, tel:+49 621 60-9 9938, and Takeda...
In April, Hitachi and Takeda Pharmaceutical formed Hitachi Inspharma to develop and maintain Takeda's information systems, with ... In April, Hitachi and Takeda Pharmaceutical formed Hitachi Inspharma to develop and maintain Takeda's information systems, with the aim of expanding the business to other drug companies....
Takeda Chemical Industries Ltd., Japan's largest drug company, is making an aggressive push into the U.S. market and using a new office here as its launching pad. Takeda Pharmaceuticals America Inc. TPA, a newly created marketing unit of the Jap Takeda Chemical Industries...
DEERFIELD, Ill. -- Following a joint meeting today of the U.S. Food and Drug Administration FDA Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development TGRD underscores its position that ACTOS([R]) pioglitazone HCl offers a proven safety profile regarding...
SUMITOMO CHEMICAL Company Ltd. and Takeda Chemical Industries Ltd. have formed a joint venture in agrochemicals, Sumika Takeda Agrochemical Company Ltd. The new company will be based in Tokyo and operate as a joint venture company for five years. S SUMITOMO CHEMICAL Company Ltd....
Osaka Gas Co., Ltd. and Kyocera Corp. (6, Takeda Tobadono-cho, Fushimi-ku, Kyoto, Japan 612-8501; Tel: 075-604-3416) have achieved an AC output power generation efficiency of 44%, according to operational assessments conducted by Osaka Gas. Based on Osaka Gas Co., Ltd. and Kyocera Corp. (6, Takeda...
ROCKVILLE, Md. and Osaka, Japan--BUSINESS WIRE--June 27, 1995-- Human Genome Sciences ("HGS") (NASDAQ:HGSI) and Takeda Chemical Industries Ltd., ("Takeda") today announced that they have entered into an Agreement where Takeda has been granted an exclusive option to license a limited number of future HGS products for development and sale in...
As PART OF ITS [epsilon]60O million (about $600 million) investment strategy for its vitamins business, BASF Aktiengesellschaft has signed an agreement with Takeda Chemical Industries Ltd. to merge their bulk vitamins businesses in a deal that will As PART OF ITS [epsilon]60O million (about...
The company will focus on health and nutrition following acquisitions. BASF POSTED record sales during its fiscal second quarter, mainly because of the strong performance of its cyclical and commodity products. But because of a refocusing of ...
Companies stress advanced technologies in new plants. THE BULK VITAMINS industry is increasing its output as suppliers expand their capacities for leading vitamins. Major producers are either raising their production or reorganizing their infr Companies stress advanced technologies in...
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
Innovative USB Sleep'n Charge. Stylish Fusion™ finish. Ultra-portable. It's clear why the Satellite® U405 is a smart choice for you and your small business. Only from the laptop expert, Toshiba.
Choose up to 5" more legroom with Economy Plus. Starting at $14.
